Replies to post #162262 on Rennova Health Inc (RNVA)

[nfrequent]

No RS should be necessary for uplisting to QB. Will probably need an RS to uplist to QX or Nasdaq. An RS to reach the QX ($4 I think) is not a problem because most investors in those exchanges will understand valuation measures, beginning with the P/E ratio which does not change on a RS.

With exceptions like some who post on this board, OTCBB pink invesors seem oblivious to valuation. They just chase unsustainable short term revenue at best but mostly MA rumors, the next shiny object (see HMBL), and the momentum they generate.

[nfrequent]

I just went through a complete list of Nasdaq listed hospitasl. Few have earnings, just losses. RNVA is outperforming all except maybe one comparable PNTG trading at a P/E of 37/1. By comparison, $4 million earnings (py) on 40 billion shares equals a P/E of 1/1. At a 37/1 P/E like PNTG, $4 million in earnings equal a PPS of .0037. Duh.